Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05012254
Title Study of Nivolumab and Ipilimumab Plus Chemotherapy as a Treatment for Patients With Stage IV Lung Cancer With Brain Metastases (NIVIPI-Brain)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Fundacion GECP

lung non-small cell carcinoma


Ipilimumab + Nivolumab

Carboplatin + Ipilimumab + Nivolumab + Paclitaxel

Cisplatin + Ipilimumab + Nivolumab + Pemetrexed Disodium

Carboplatin + Ipilimumab + Nivolumab + Pemetrexed Disodium

Age Groups: senior | adult
Covered Countries ESP

Additional content available in CKB BOOST